The quick read
Latest quote·Oct 16
No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Enbridge Inc (ENB) insiders filed no open-market purchases or sales in the 90 days to Oct 18, 2026, according to SEC Form 4 filings.
Rep. Brian Babin (R) sold $1K to $15K on May 5, 2026, disclosed 13 days later. In total, 1 member disclosed 1 ENB trade with trade dates in the last 180 days, filed a median 13 days after trading.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position.
Buys/Adds (2)
D.E. Shaw
$136.9M
added
AQR
$23.4M
added
Sells/Trims (1)
Millennium
$14.8M
trimmed
Sells (1)
No tracked top-trader positions in ENB right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 31, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.43 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 31, 2026 | $0.46 / $0.43Alpha Vantage | +6.98% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 8, 2026 | $0.71 / $0.69Alpha Vantage | +2.90% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 13, 2026 | $0.88 / $0.78Alpha Vantage | +12.82% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 7, 2025 | $0.46 / $0.51Alpha Vantage | -9.80% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 1, 2025 | $0.65 / $0.57Alpha Vantage | +14.04% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 9, 2025 | $1.03 / $0.95Alpha Vantage | +8.42% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 14, 2025 | $0.75 / $0.74Alpha Vantage | +1.35% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 1, 2024 | $0.55 / $0.56Alpha Vantage | -1.79% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$0.47 to $0.56
Revenue expected
2 analysts
Last 30 days
Analysts cutting estimates
| USD | Sep 2023 | Jun 2025 | Dec 2025 |
|---|---|---|---|
| What came in | |||
| Revenue | $9.84B | $14.88B | $17.18B |
| Cost of what it sold | $6.00B | $9.95B | $11.51B |
| Gross profit | $3.85B | $4.93B | $5.67B |
| What it spent | |||
| Sales and admin | $34.0M | $2.33B | $2.70B |
| Other operating costs | $2.02B | $308.0M | $241.0M |
| Total operating expenses | $2.06B | $2.64B | $2.94B |
| What was left | |||
| Operating profit | $1.79B | $2.29B | $2.73B |
| Interest on debt | $921.0M | $1.18B | $1.22B |
| Profit before tax | $751.0M | $2.99B | $2.46B |
| Tax | $128.0M | $666.0M | $325.0M |
| Net profit | $621.0M | $2.28B | $2.06B |
| EBITDA | $2.84B | $5.56B | $5.13B |
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace